APOE ε4与认知及痴呆的关联中神经病理影像标志物的中介作用
基于鹿特丹研究人群队列,纳入5510名接受脑MRI的参与者,采用因果中介分析探讨APOE ε4通过海马体积、白质高信号、阿尔茨海默病特异性皮质厚度及脑微出血对认知和痴呆的中介效应。结果显示,APOE ε4对认知的影响约四分之一由影像标志物中介,主要由脑微出血驱动;对痴呆的中介作用有限。
要点
- APOE ε4对认知的效应约25%由脑微出血中介,12%由白质高信号中介。
- APOE ε4携带者痴呆风险升高(HR 2.35,95%CI 2.06-2.65)。
- 影像标志物对APOE ε4与痴呆关联的中介作用有限,4种标志物合计仅解释6%。
核心结论
- APOE ε4对认知的影响约四分之一由结构性脑影像标志物中介,主要由脑微出血驱动;对痴呆的中介作用有限。
研究设计与样本
- 基于鹿特丹研究人群队列,纳入2005至2009年间接受脑MRI的5510名参与者,平均年龄65.0(±10.9)岁,55.0%为女性。
- 认知横断面评估,痴呆随访至2020年1月1日,采用因果中介分析分解APOE ε4的总效应。
主要发现
- 5510名参与者中349例发生痴呆,其中148例为ε4携带者。
- ε4携带者整体认知Z评分略低(β=-0.02,95%CI -0.07至0.02),相当于年龄相关认知下降4.4个月。
- 海马体积中介认知关联的7%(β=-0.00,95%CI 0.00-0.00),皮质厚度中介4%(β=-0.00,95%CI -0.01至0.00)。
- 脑微出血中介认知关联的25%(p=0.24,β=-0.00,95%CI -0.01至0.00),白质高信号中介12%(p=0.44,β=-0.00,95%CI -0.01至0.00)。
- 多中介分析中,白质高信号和脑微出血合计中介认知效应的27%(p=0.48)。
临床怎么用
- 在APOE ε4携带者中,脑微出血和白质高信号可能部分解释认知下降,提示脑血管病负担的评估价值。
- APOE ε4对痴呆的风险关联大部分不通过所测影像标志物中介,提示其他路径参与。
- 中介分析结果需谨慎解读,部分中介效应未达统计学显著性。
局限性
- 部分中介效应估计的p值未达统计学显著性(如脑微出血对认知p=0.24,对痴呆p=0.06)。
- 影像标志物仅覆盖结构性MRI指标,未包括功能或分子病理标志物。
- 认知为横断面评估,无法反映纵向认知变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Insight into APOE-related pathways is important to unravel pathophysiology and identify therapeutic targets against late-life cognitive decline. We aimed to estimate mediators of APOE ε4 on cognition and dementia through different disease markers on structural in vivo brain imaging. METHODS: All participants from the population-based Rotterdam Study who underwent brain MRI between 2005 and 2009 were included. Cognition was assessed cross-sectionally during center visits, and participants were followed up for incident dementia until January 1, 2020. Imaging markers included hippocampal volume (HV), volume of white matter hyperintensities (WMHs), Alzheimer disease-specific regional cortical thickness, and presence of ≥2 cerebral microbleeds. We performed causal mediation analyses to decompose the total effect of APOE ε4 carriership on cognition and dementia into natural direct and indirect effects and corresponding percentage mediated. We adjusted models for potential confounders. RESULTS: Among 5,510 participants (mean age at time of MRI scan: 65.0 [±10.9] years, 55.0% women), 349 developed dementia, of whom 148 were ε4 carriers. Carriers of ε4 had slightly lower Z-scores for global cognition (β = -0.02 [-0.07 to 0.02], age-related cognitive decline = 4.4 months), with 7% (β = -0.00 [0.00-0.00]) of this association mediated by HV and 4% (β = -0.00 [-0.01 to 0.00]) by cortical thickness. In total, an estimated 25% of the effect of ε4 on cognition was mediated by microbleeds (p value = 0.24, [β = -0.00 {-0.01 to 0.00}]) and 12% by WMHs (p value = 0.44, [β = -0.00 {-0.01 to 0.00}]). In multiple mediator analyses, WMHs and microbleeds together accounted for 27% of the mediated effect of APOE ε4 on cognition (p value = 0.48). Carriers of ε4 had higher risk of incident dementia (HR 2.35 [95% CI 2.06-2.65]). For dementia, there was little to no evidence of mediation by either HV (3%, p value = 0.09, OR = 1.01 [1.00-1.03]) or regional cortical thickness (0%, p value = 0.79, OR = 1.00 [0.99-1.02]). In total, 1% of the effect of ε4 on dementia was mediated by WMHs (p value 0.29, OR = 1.00 [1.00-1.02]) and 5% by microbleeds (p value = 0.06), OR = 1.03 (1.00-1.07). In multiple mediator analyses, all 4 imaging markers together explained 6% of the mediated effect on incident dementia (p value = 0.04). DISCUSSION: In this population-based cohort study, we found that an estimated one-fourth of the effect of APOE ε4 on cognition is mediated by structural brain imaging markers, driven mainly by cerebral microbleeds. For dementia, mediation by these markers was limited.
引用
- Claus JJ, Rosbergen MT, Labrecque JA, et al. Mediation of the Association Between APOE ε4 Genotype, Cognition, and Dementia by Neuropathology Imaging Markers in the Rotterdam Study. Neurology. 2025. PMID: 40344552. doi:10.1212/WNL.0000000000213679
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。